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Introduction: The quality of cartilaginous tissue derived from bone marrow mesenchymal stromal stem cell (BMSC)
transplantation has been correlated with clinical outcome. Therefore, culture conditions capable of modulating
tissue phenotype, such as oxygen tension and scaffold composition, are under investigation. The objective of this
study was to assess the effect of hypoxia on in vitro BMSC chondrogenesis within clinically approved porous
scaffolds composed of collagen and hyaluronic acid (HA). It was hypothesized that hypoxic isolation/expansion
and differentiation would improve BMSC chondrogenesis in each construct.
Methods: Ovine BMSCs were isolated and expanded to passage 2 under hypoxia (3% oxygen) or normoxia (21% oxygen).
Cell proliferation and colony-forming characteristics were assessed. BMSCs were seeded at 10 million cells per cubic
centimeter on cylindrical scaffolds composed of either collagen I sponge or esterified HA non-woven mesh. Chondrogenic
differentiation was performed in a defined medium under hypoxia or normoxia for 14 days. Cultured constructs were
assessed for gene expression, proteoglycan staining, glycosaminoglycan (GAG) quantity, and diameter change.
Results: Isolation/expansion under hypoxia resulted in faster BMSC population doublings per day (P <0.05), whereas cell
and colony counts were not significantly different (P = 0.60 and 0.30, respectively). Collagen and HA scaffolds seeded with
BMSCs that were isolated, expanded, and differentiated under hypoxia exhibited superior aggrecan and collagen II mRNA
expressions (P <0.05), GAG quantity (P <0.05), and proteoglycan staining in comparison with normoxia. GAG/DNA was
augmented with hypoxic isolation/expansion in all constructs (P <0.01). Comparison by scaffold composition indicated
increased mRNA expressions of hyaline cartilage-associated collagen II, aggrecan, and SOX9 in collagen scaffolds, although
expression of collagen X, which is related to hypertrophic cartilage, was also elevated (P <0.05). Proteoglycan deposition
was not significantly improved in collagen scaffolds unless culture involved normoxic isolation/expansion followed by
hypoxic differentiation. During chondrogenesis, collagen-based constructs progressively contracted to 60.1% ± 8.9% of
the initial diameter after 14 days, whereas HA-based construct size was maintained (109.7% ± 4.2%).
Conclusions: Hypoxic isolation/expansion and differentiation enhance in vitro BMSC chondrogenesis within porous
scaffolds. Although both collagen I and HA scaffolds support the creation of hyaline-like cartilaginous tissue, variations in
gene expression, extracellular matrix formation, and construct size occur during chondrogenesis.* Correspondence: adesida@ualberta.ca
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Table 1 Bone marrow donor information
Donor Gender Age, years Mass, kilograms
Z28 Female 2.0 66
Z01 Female 2.2 71
Z33 Female 2.3 81
Y19 Female 3.2 63
Y08 Female 3.3 94
T10 Female 7.0 74
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Bone marrow-derived mesenchymal stromal stem cells
(BMSCs) are a promising cell-based option for treating ar-
ticular cartilage defects [1-6]. Clinical and pre-clinical
studies have shown variable outcomes following BMSC
transplantation for treatment of focal chondral and osteo-
chondral defects [7]. Repair tissues consistent with hyaline
cartilage, fibrocartilage, and mixed tissue have been re-
ported [2-4]. Clinical scores correlate with quality of car-
tilaginous repair tissue on the basis of magnetic resonance
imaging and histological analysis [2,4,6]. Therefore, cul-
ture conditions capable of improving cell and tissue
phenotype are currently under investigation.
Incubator oxygen tension is a culture variable that has
gained attention on the basis of the posited role of oxygen
in musculoskeletal tissue development and cellular micro-
environments. There is evidence to suggest that hypoxia
promotes chondrogenic differentiation of BMSCs during
pre-natal limb development [8]. Furthermore, BMSCs exist
in hypoxic bone marrow spaces, whereas chondrocytes res-
ide within avascular hyaline cartilage and are bathed in hyp-
oxic synovial fluid [9,10].
The positive impact of hypoxia on BMSC proliferation
has been demonstrated on the basis of cell count, nu-
cleoside incorporation, and colony-forming capability
[11-15]. During prolonged expansion periods, stem cell
characteristics such as rapid proliferation and multipo-
tency are maintained with hypoxic incubation [11,12],
whereas senescence is delayed [16]. Hypoxic BMSC iso-
lation and expansion [13-15,17,18] and hypoxic BMSC
differentiation [12-15,17,19] have separately been asso-
ciated with improved in vitro chondrogenesis within
pellet, micromass, and hydrogel models. Three studies
have compared the impact of hypoxic isolation/expan-
sion with hypoxic differentiation on chondrogenesis,
and variable improvements in gene expression and car-
tilaginous extracellular matrix (ECM) formation were
found with hypoxic exposure during each distinct cul-
ture period [14,15,19].
Although hypoxic enhancement of BMSC chondrogenesis
has been studied extensively in pellet, micromass, and
hydrogel models, this effect has not been elucidated in detail
in porous scaffolds. Porous scaffolds composed of natural
and synthetic materials allow cells to permeate, adhere, and
organize within a three-dimensional (3D) environment, and
deposit ECM to form tissue [20]. As a result, they serve as a
suitable model for studying 3D cartilage formation in vitro
[7]. Moreover, porous scaffolds composed of collagen or
hyaluronic acid (HA) are commonly used in clinical BMSC
transplantation [2-5,21]. At present, it is not known whether
hypoxic culture improves chondrogenesis of BMSCs seeded
on 3D porous scaffolds. Accordingly, the first objective
of this study was to assess the effect of oxygen tension
during distinct isolation/expansion and differentiationculture periods on chondrogenesis within BMSC-seeded
porous scaffolds. The impact of porous scaffold material
on the modulation of chondrogenesis with oxygen ten-
sion has not been elucidated. Therefore, the second ob-
jective of this study was to investigate differences in
chondrogenesis between BMSCs seeded and cultured
on a collagen I porous scaffold and an esterified HA
porous scaffold. It was hypothesized that hypoxic incu-
bation during isolation/expansion and differentiation
culture periods would improve BMSC chondrogenesis
within each scaffold.Methods
Bone marrow aspiration and mononucleated cell
counting
Bone marrow-derived cell collections for this study were
obtained from iliac crest aspirates from six skeletally ma-
ture, female Suffolk sheep (mean age ± standard error of
the mean (SEM) of 3.3 ± 0.8 years). Characteristics of each
sheep are summarized in Table 1. General anesthesia for
the aspiration procedure was attained through sedation
with intravenous dexmedetomidine (5 μg/kg) and keta-
mine (2 mg/kg) followed by endotracheal intubation and
administration of gaseous isoflurane (2% to 4% in oxygen).
The sheep were then positioned in a lateral decubitus pos-
ition, and the posterolateral pelvic surgical site was clipped
and prepared with 10% wt/vol povidone-iodine solution
(Betadine; Purdue Pharma L.P., Stamford, CT, USA). A
small incision was made over the posterior ilium, and an
11-gauge Jamshidi needle (Cardinal Health Canada Inc.,
Vaughan, ON, Canada) was inserted onto the iliac crest
near the posterior superior iliac spine and through cortical
bone into the marrow space. Bone marrow aspirate (mean
volume ± SEM of 33 ± 2 mL) was collected and mixed im-
mediately with 8 mL of heparin (10,000 units per 10 mL;
Pharmaceutical Partners of Canada Inc., Richmond Hill,
ON, Canada). Aspirates were then filtered with a cell
strainer (100-μm pore size; Becton Dickinson Canada Inc.,
Mississauga, ON, Canada). The number of mononucle-
ated cells (MNCs) in each aspirate was determined by
crystal violet nuclei staining and cell counting by using a
hemocytometer.
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mesenchymal stem cells
Bone marrow aspirate collections containing 8 × 107
MNCs were seeded within each 150-cm2 tissue culture
flask. Culture medium composed of alpha-minimal
essential medium (α-MEM) supplemented with 10% vol/
vol heat-inactivated fetal bovine serum (FBS), penicillin-
streptomycin-glutamine, 4-(2-hydroxyethyl)-1-piperazi-
neethanesulfonic acid (HEPES), and sodium pyruvate
(all from Life Technologies, Burlington, ON, Canada)
was pipetted into each flask. Fibroblast growth factor-2
(FGF-2) (Neuromics Inc., Edina, MN, USA) was added
at a concentration of 5 ng/mL in order to maintain cell
multipotency [22]. Nucleated cells were allowed to ad-
here and grow for 7 days before the first media change
under normoxia (ambient 21% O2) or hypoxia (low 3%
O2) at 37°C in a humidified incubator containing 5%
CO2. Flasks from the hypoxic incubator experienced
short periods (<5 minutes) of normoxic exposure during
media changes. Thereafter, the media were changed
twice per week until 80% cell confluence was obtained.
Adherent BMSCs were detached by using 0.05% wt/vol
trypsin-ethylenediaminetetraacetic acid (EDTA) (Sigma-
Aldrich, Oakville, ON, Canada) and expanded under the
same oxygen tension (normoxia or hypoxia) as during
isolation until passage 2 (P2) prior to scaffold seeding.
Hereafter for brevity, BMSCs described by expansion
oxygen tension alone (normoxia-expanded and hypoxia-
expanded BMSCs) will refer to BMSCs that were iso-
lated and expanded under normoxia and hypoxia,
respectively. The time taken from plating of nucleated
cells (P0) to reach approximately 80% confluence at P2,
before experimental use, varied from 3 to 4 weeks.
Colony-forming unit fibroblastic assay
A colony-forming unit fibroblastic (CFU-F) assay was con-
ducted to determine the effect of oxygen tension on
colony-forming characteristics of BMSCs and to calculate
the proportion of plastic-adherent cells (BMSCs) derived
from bone marrow aspirates containing a known number
of MNCs. MNCs from each donor were plated in triplicate
at 1 × 105 MNCs per 100-mm-diameter sterile petri dish
(Becton Dickinson Canada Inc.) and cultured as described
for expansion conditions under normoxia (21% O2) or hyp-
oxia (3% O2) by using α-MEM supplemented with 10% vol/
vol heat-inactivated FBS, penicillin-streptomycin, HEPES,
sodium pyruvate, and 5 ng/mL FGF-2. After the first week,
the non-adherent cell population was removed by aspir-
ation and culture media were replenished twice each week.
During media changes, hypoxia-cultivated cells experienced
a short period (<5 minutes) of exposure to normoxia. The
total duration of culture time used for each donor (mean ±
SEM of 16.3 ± 0.5 days) was equivalent to the time required
to attain 80% BMSC confluence at P0 and subsequentdetachment and splitting to P1 for expansion in T150
flasks (see ‘Isolation and expansion of bone marrow-
derived mesenchymal stem cells’ section). For each donor,
the culture times for petri dishes placed in hypoxic and
normoxic conditions were identical. After the CFU-F cul-
ture period finished, the petri dishes were fixed with 10%
wt/vol buffered formalin (3.8% wt/vol formaldehyde),
washed by using phosphate-buffered saline (PBS) (Life
Technologies), and stained with 0.25% wt/vol crystal violet
solution (Sigma-Aldrich). During analysis, each stained
cell collection was assessed and considered to be a colony
only if (a) the cell collection was stained strongly with
crystal violet, (b) the periphery of the collection was circu-
lar and well defined with respect to the surrounding area
of the plate that was not stained, and (c) the diameter of
the stained cell collection was measured to be at least
2 mm. The number of BMSC colonies in each dish was
recorded, as was the diameter of each colony.
Bone marrow-derived mesenchymal stem cell counts and
doubling
Total cell counts of trypsinized BMSCs at P0, P1, and P2
were calculated by using trypan blue staining and
hemocytometer counting of small aliquots of BMSCs in
expansion medium. The number of colonies noted in
each CFU-F assay was used to determine the number of
BMSCs isolated per 1 × 105 MNCs plated for each donor,
and this was extrapolated to calculate the number of
BMSCs arising from 8 × 107 MNCs plated in each T150
culture flask during P0 expansion. Population doublings
were determined by using the method described by
Solchaga et al. [22].
Trilineage differentiation potential of bone
marrow-derived mesenchymal stem cells
Osteogenic differentiation was performed by plating 5 × 103
BMSCs/cm2 within wells of a six-well plate (Becton
Dickinson Canada Inc.) and culturing these in 2.5 mL of
osteogenic medium for 21 days at 37°C in a humidified
hypoxic incubator (3% O2 and 5% CO2). Osteogenic
medium consisted of Dulbecco’s modified Eagle’s medium
(DMEM) containing 4.5 mg/mL D-glucose, 0.1 mM non-
essential amino acids, 1 mM sodium pyruvate, 100 mM
HEPES, 100 U/mL penicillin, 100 μg/mL streptomycin,
0.29 mg/mL L-glutamine (all from Life Technologies) sup-
plemented with 10% vol/vol heat-inactivated FBS, 0.1 mM
ascorbic acid 2-phosphate, 10 nM dexamethasone, and
10 mM β-glycerophosphate (Sigma-Aldrich). Media
changes were performed twice per week. After the culture
period, the contents of each well were fixed with 10% wt/
vol buffered formalin (3.8% wt/vol formaldehyde), stained
for 30 minutes with 1% wt/vol Alizarin Red S (Sigma-
Aldrich) with an adjusted pH of 4.2, washed with distilled
water over 60 minutes, and stored at 4°C in 70% vol/vol
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NJ, USA). Images were captured by using an Omano
OM159T biological trinocular microscope (Microscope
Store, Roanoke, VA, USA) fitted with an Optixcam Sum-
mit Series 5MP digital camera and Optixcam software and
assembled in Photoshop (Adobe Systems Inc., San Jose,
CA, USA).
Adipogenic differentiation was performed on BMSCs
plated at 5 × 103 BMSCs/cm2 within wells of a six-well
plate (Becton Dickinson Canada Inc.). Plated BMSCs were
initially cultured in basic culture medium of 2.5 mL of
DMEM containing 4.5 mg/mL D-glucose, 0.1 mM non-
essential amino acids, 1 mM sodium pyruvate, 100 mM
HEPES, 100 U/mL penicillin, 100 μg/mL streptomycin,
and 0.29 mg/mL L-glutamine supplemented with 10%
vol/vol heat-inactivated FBS (all from Life Technologies).
Adipogenesis was then induced over the course of 3 days
in 2.5 mL of basic culture medium supplemented with
1 μM dexamethasone, 0.5 mL insulin-transferrin-selenium
(ITS) + 1, 100 μM indomethacin, and 500 μM isobutyl-1-
methylxanthine (IBMX) (Sigma-Aldrich), followed by
1 day of culture in 2.5 mL of basic culture medium sup-
plemented with only 0.5 mL ITS + 1. This 4-day cycle was
repeated three times, followed by culture for 7 days in
2.5 mL of basic culture medium supplemented with only
0.5 mL ITS + 1. All culture was performed in a hypoxic
humidified incubator (3% O2 and 5% CO2). After the cul-
ture period, the contents of each well were fixed with 10%
wt/vol buffered formalin (3.8% wt/vol formaldehyde),
stained for 60 minutes with 0.3% wt/vol Oil Red O
(Sigma-Aldrich), washed with distilled water, and assessed
immediately for staining. Oil Red O solution was prepared
by creating a 0.5% wt/vol solution of Oil Red O (Sigma-
Aldrich) in isopropanol (Fisher Scientific Chemical Div-
ision) and then diluting this to 0.3% wt/vol in an equivalent
volume of distilled water. Microscopic images were cap-
tured in an identical fashion to osteogenic culture products.
Chondrogenic differentiation was verified by using a pellet
culture system. BMSCs were suspended in chondrogenic
medium consisting of DMEM containing 4.5 mg/mL D-
glucose, 0.1 mM non-essential amino acids, 1 mM sodium
pyruvate, 100 mM HEPES, 100 U/mL penicillin, 100 μg/mL
streptomycin, 0.29 mg/mL L-glutamine (all from Life Tech-
nologies) supplemented with 0.1 mM ascorbic acid 2-
phosphate, 0.1 μM dexamethasone, 1x ITS + 1 premix
(Sigma-Aldrich), and 10 ng/mL transforming growth
factor-beta 3 (TGF-β3) (Neuromics Inc.). In total, 5 × 105
BMSCs were spun within 1.5-mL sterile conical polypro-
pylene microfuge tubes (Enzymax LLC, Lexington, KY,
USA) at 1,500 revolutions per minute for 5 minutes to
form spherical cell pellets. Pellets were then submersed in
500 μL of chondrogenic medium and cultured in a hyp-
oxic humidified incubator (3% O2 and 5% CO2) for
21 days. Pellets experienced a short period (<5 minutes) ofexposure to normal oxygen tension during media changes.
After the culture period, BMSC pellets were processed
and stained for histological analysis of cartilaginous pro-
teoglycans (see ‘Histological and immunohistochemical
analyses of extracellular matrix contents’ section).
Porous scaffold seeding and chondrogenic differentiation
of bone marrow-derived mesenchymal stem cell-seeded
scaffolds
Cylindrical collagen scaffolds (3.5-mm thickness and 6-mm
diameter) were created by using a biopsy punch on sheets of
porous, type I collagen sponge (125 × 100 × 3.5 mm3 dimen-
sion and 115 ± 20 μm pore size; Integra LifeSciences Corp.,
Plainsboro Township, NJ, USA). Cylindrical HA scaffolds
(2-mm thickness and 6-mm diameter) were created by using
a biopsy punch on sheets of esterified HA (HYAFF) non-
woven mesh (20 × 20 × 2 mm3 dimensions and 10- to 20-
μm-diameter fibers with varying inter-fiber spaces [23];
Anika Therapeutics S.r.l., Abano Terme, PD, Italy). Scaffold
seeding was performed at a consistent density of 1 × 107
BMSCs/cm3, which corresponded to 989,602 BMSCs seeded
per collagen scaffold and 565,487 BMSCs seeded per HA
scaffold [24].
During seeding, BMSCs at P2 were re-suspended in
chondrogenic culture medium (see ‘Trilineage differenti-
ation potential of bone marrow-derived mesenchymal
stem cells’ section). Total cell counts were calculated from
trypan blue staining and hemocytometer counting of small
aliquots of BMSCs. BMSCs were micropipetted onto each
scaffold within a 20-μL chondrogenic medium suspension.
HA scaffolds were pre-soaked with 20 μL of chondrogenic
medium to promote dispersion of the cell suspension over
the scaffold during seeding. Seeded scaffolds were then in-
cubated at 37°C for 15 minutes followed by the addition
of 100 μL of chondrogenic medium to the base of each
scaffold. Thereafter, constructs were incubated for an add-
itional 30 minutes to promote cell adhesion. All con-
structs, including cell-free scaffolds (control group) and
those seeded with either normoxia- or hypoxia-expanded
BMSCs, were subsequently immersed in 1 mL of chon-
drogenic medium and cultured statically at 37°C within
humidified incubators containing 5% CO2 and either 21%
O2 (normoxia) or 3% O2 (hypoxia). Media were changed
twice weekly thereafter.
Oxygen tension experimental groups
To determine the effect of oxygen tension during isola-
tion/expansion and differentiation on in vitro chondro-
genesis within BMSC-seeded scaffolds, BMSCs from five
donors (Z28, Z01, Z33, Y19, and T10) with a mean age
(± SEM) of 3.3 ± 0.9 years were seeded onto collagen
and HA scaffolds and cultured in chondrogenic medium
for 14 days. The experimental set-up is illustrated in
Figure 1. The treatment groups included the following:
Figure 1 In vitro cartilage engineering from bone marrow-derived mesenchymal stem cell (BMSC)-seeded porous scaffolds. BMSCs were isolated by plastic
adherence from bone marrow aspirates and expanded in tissue culture flasks to passage 2 within defined expansion medium containing fetal bovine serum
and fibroblast growth factor-2 under either normoxic (21% O2) or hypoxic (3% O2) incubator conditions. Thereafter, BMSCs were seeded at 10 million cells per
cubic centimeter onto clinically approved, cylindrical, porous scaffolds composed of collagen or hyaluronic acid. BMSC-scaffold constructs were subsequently
cultured under either normoxia or hypoxia for 14 days within serum-free chondrogenic medium containing transforming growth factor-beta 3 and
dexamethasone.
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entiation under hypoxia), Hyp/Nrx (isolation and expansion
under hypoxia and differentiation under normoxia), Nrx/
Hyp (isolation and expansion under normoxia and differen-
tiation under hypoxia), and Nrx/Nrx (isolation and expan-
sion under normoxia and differentiation under normoxia).
After culture, the tissue-engineered constructs were assessed
with reverse transcription-quantitative real-time polymerase
chain reaction (RT-qPCR) for gene expression, histological
staining of ECM proteoglycans, collagen II immunohisto-
chemistry, and biochemical quantification of glycosamino-
glycan (GAG) and DNA.
Reverse transcription-quantitative real-time polymerase
chain reaction analysis of chondrogenic genes
Total RNA was extracted from constructs by using TRIzol
Reagent (Life Technologies) after grinding with a pestle. To
mitigate changes in gene expression, constructs under hyp-
oxia and normoxia were immediately transferred into TRI-
zol Reagent following removal from respective incubators.
Total RNA (100 ng) in a 40-μL reaction was reverse-
transcribed to cDNA by using a GoScript Reverse Tran-
scription System (Promega Corporation, Madison, WI,
USA) primed in the presence of oligo(dT) primers (1 μg).
Quantitative polymerase chain reaction was performed witha DNA Engine Opticon II Continuous Fluorescence Detec-
tion System (Bio-Rad Laboratories, Hercules, CA, USA) by
using HotGoldStar Taq polymerase and SYBR Green detec-
tion (Eurogentec North America Inc., San Diego, CA, USA).
Primer sequences (Table 2) were created by using informa-
tion from the National Center for Biotechnology Informa-
tion (NCBI) database and custom-designed by using the
Primer Express software (Applied Biosystems, Foster City,
CA, USA). All primers were obtained from Invitrogen (Life
Technologies). Gene (mRNA) expression levels for each pri-
mer set were normalized to the expression level of ovine β-
actin by the 2−ΔΔC(T) method [25].
RT-qPCR products were subsequently sequenced to
confirm that expression levels were based on appropri-
ate sequences for each gene. For sequencing, RT-qPCR
products were purified by using a QIAquick Gel Extrac-
tion Kit (Qiagen Inc. Canada, Toronto, ON, Canada),
combined with each primer (forward and reverse
primers separately), and sequenced by using the Sanger
method (The Applied Genomics Centre, University of
Alberta, Edmonton, AB, Canada). The resulting traces
were read by using FinchTV Software Version 1.5
(Geospiza Inc., Seattle, WA, USA) and matched to cor-
responding regions within characterized gene sequences
by using the nucleotide Basic Local Alignment Search
Table 2 Ovine primer sequences used in reverse transcription-quantitative real-time polymerase chain reaction
analysis
Gene Primer sequences NCBI reference
β-actin (ACTB) 5′-CGGCGGGACCACCAT-3′ Forward NM_001009784.1
5′-GCAGTGATCTCTTTCTGCATCCT-3′ Reverse
Aggrecan (ACAN) 5′-TGGAATGATGTCCCATGCAA-3′ Forward XM_004018048.1
5′-GCCACTGTGCCCTTTTTACAG-3′ Reverse
COMP (COMP) 5′-CCTAACTGGGTGGTGCTCAAC-3′ Forward XM_004009150.1
5′-CTGGGTCGCTGTTCATCGT-3′ Reverse
Collagen I (COL1A1) 5′-CGCCCCAGACCAGGAATT-3′ Forward XM_004012773.1
5′-GTGGAAGGAGTTTACAGGAAGCA-3′ Reverse
Collagen II (COL2A1) 5′-GACCTCACGTCTCCCCATCA-3′ Forward XM_004006408.1
5′-CTGCTCGGGCCCTCCTAT-3′ Reverse
Collagen X (COL10A1) 5′-CAGGCTCGAATGGGCTGTAC-3′ Forward XM_004011185.1
5′-CCACCAAGAATCCTGAGAAAGAG-3′ Reverse
SRY-Box 9 (SOX9) 5′-GCTGCTGGCCGTGATGA-3′ Forward XM_004013527.1
5′-GGGTCGCGCGTTTGTTT-3′ Reverse
NCBI, National Center for Biotechnology Information.
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within Additional file 1.
Histological and immunohistochemical analyses of
extracellular matrix contents
Pellets and scaffold-based constructs were removed from
media, fixed in 10% wt/vol buffered formalin (3.8% wt/
vol formaldehyde), processed into paraffin wax, and sec-
tioned at a thickness of 5 μm. Sections were stained with
0.1% wt/vol safranin O to reveal proteoglycan matrix de-
positions and counterstained with 1% wt/vol fast green.
Other sections from scaffold-based constructs were
treated with chondroitinase (Sigma-Aldrich) at 0.2 U per
section and incubated with an antibody against collagen
II (II-II6B3 from Developmental Studies Hybridoma
Bank at the University of Iowa, Iowa City, IA, USA; 1:50
dilution). Immune-localized antigens were visualized with
horse anti-mouse IgG biotinylated secondary antibody
(Vectastain; Vector Laboratories Inc., Burlingame, CA,
USA) and an aminoethylcarbazole (AEC)-based peroxidase
labeling kit (Enzo Life Sciences Inc., Farmingdale, NY,
USA). Images were captured by using an Eclipse Ti-S
microscope (Nikon Canada Inc., Mississauga, ON, Canada)
fitted with NIS Elements Basic Research Imaging Software
Version 4.20 (Nikon Canada Inc.) and assembled in
Photoshop.
Biochemical analysis of glycosaminoglycan and DNA
quantity
In vitro cultured BMSC-scaffold constructs were rinsed in
PBS and digested in proteinase K (1 mg/mL in 50 mM Tris
with 1 mM EDTA, 1 mM iodoacetamide, and 10 mg/mL
pepstatin A; all from Sigma-Aldrich) for 16 hours at 56°C.Sulfated GAG content was measured by 1,9-dimethyl-
methylene blue binding (Sigma-Aldrich) by using chondro-
itin sulfate (Sigma-Aldrich) as the standard. DNA content
was determined by using the CyQUANT Cell Proliferation
Assay Kit (Life Technologies) with supplied bacteriophage
λ DNA as the standard.
Analysis of bone marrow-derived mesenchymal stem
cell-scaffold construct size
To characterize changes in diameter with culture time,
BMSC-seeded scaffolds (five per donor) were photo-
graphed with a high-quality digital camera after 7 and
14 days of in vitro chondrogenic culture. Each image
was evaluated for diameter changes as previously de-
scribed [26,27]. The diameter of each scaffold was mea-
sured in four separate planes with ImageJ software
(National Institutes of Health, Bethesda, MD, USA), and
the resulting mean diameter was expressed as a percent-
age change from the initial diameter at the time of seed-
ing [26].
Statistical analysis
Analyses were performed by using SPSS Statistics 22 (IBM
Corporation, Armonk, NY, USA), and a P value of less
than 0.05 was considered significant. Proliferation analyses
used a repeated measures analysis of variance (ANOVA)
for BMSC count and doublings over time, and a t test was
used for assessment of these parameters on specific cul-
ture days. CFU-F analysis involved a Mann-Whitney U
test for assessment of colony count and diameter. For ana-
lyses of gene expression and biochemical quantities, a
Kruskal-Wallis one-way ANOVA was used to determine
differences between the four experimental groups with
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test was used for pooled analyses. For analysis of construct
diameter, a repeated measures ANOVA was used to deter-
mine differences between the four experimental groups over
time, and a t test was used for pooled analysis at each time
point.
Ethical considerations
All experiments were implemented with BMSCs isolated
from bone marrow aspirates taken from adult sheep after
ethical approval from the University of Alberta’s Animal
Care and Use Committee.
Results
Hypoxic isolation and expansion to passage 2 may
enhance bone marrow-derived mesenchymal stem cell
proliferation
Similar cell counts were found for hypoxia- and normoxia-
expanded BMSCs throughout the expansion period (P =
0.60, Figure 2A). At the end of P2, there were 26.5 ± 3.6
million and 23.2 ± 4.7 million BMSCs yielded from each
T150 flask plated at P0 and expanded under hypoxia andFigure 2 Expansion and trilineage differentiation of bone marrow-derived m
per day, and (C) cumulative population doublings at each passage during exp
mean ± standard error of the mean of cells from six donors, and P values are
staining following expansion under hypoxia and monolayer culture within m
serum. (E) Adipogenic differentiation of BMSCs verified with Oil Red O stainin
medium containing isobutyl-1-methylxanthine (IBMX), indomethacin, dexame
BMSCs verified by safranin O staining following expansion under hypoxia and
(middle) or hyaluronic acid (right) submersed in a defined serum-free chondr
dexamethasone.normoxia, respectively. Five of six donors had higher BMSC
counts under hypoxia (Figure 2A inset). However, mean
values were not statistically different (P = 0.74). Population
doublings per day were highest at P0 and decreased signifi-
cantly with subsequent passages (P = 0.02; Figure 2B).
Hypoxia-expanded BMSCs had higher population dou-
blings per day than normoxia-expanded BMSCs through-
out the expansion period (P <0.05). Cumulative population
doublings were not different between groups (P = 0.67;
Figure 2C). Values of mean time (± SEM) between plating
at P0 and 80% BMSC confluence at the end of P2 were
23.4 ± 0.8 days for hypoxia-expanded BMSCs and 25.3 ±
1.5 days for normoxia-expanded BMSCs (P = 0.38).
A CFU-F assay was performed to determine the effect of
oxygen tension on colony-forming characteristics of adher-
ent BMSCs isolated from plated MNCs and cultured in ex-
pansion medium under normoxia and hypoxia. Colony
counts and diameters were assessed at the end of P0 when
corresponding BMSCs undergoing expansion in T150
flasks had reached 80% confluence (16.3 ± 0.5 days of
culture). Seeded petri dishes from one donor (Z01)
lacked colony formation over this period. Hypoxicesenchymal stem cells (BMSCs). (A) Cell counts, (B) population doublings
ansion of BMSCs under normoxia or hypoxia. Data points represent
listed. (D) Osteogenic differentiation of BMSCs verified with Alizarin Red S
edium containing β-glycerophosphate, dexamethasone, and fetal bovine
g following expansion under hypoxia and monolayer culture within
thasone, and fetal bovine serum. (F) Chondrogenic differentiation of
culture performed in pellets (left) or scaffolds composed of collagen
ogenic medium containing transforming growth factor-beta 3 and
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petri dishes seeded with cells from four of the remaining
five donors (Figure 3A-J), although there was not a sig-
nificant difference in mean colony counts between the
groups (P = 0.30 for triplicate dishes and P = 0.22 for
best-growth dishes; Figure 3K and L). Crystal violet
staining of adherent cells in hypoxia- and normoxia-
cultured dishes showed the presence of a spectrum of
cell morphologies ranging from long, spindle-shaped
cells to circular and cuboidal cells (Figure 3M and N).
No difference was noted in colony diameter between
culture groups (P = 0.36; Figure 3L).Trilineage differentiation of adherent bone
marrow-derived mesenchymal stem cells
Plastic-adherent BMSCs were expanded to P2 and dif-
ferentiated in vitro toward bone, adipose, and cartilage
tissue lineages to confirm multilineage potential [28].
Tissue derived from BMSCs stained extensively with
Alizarin Red S (Figure 2D) and Oil Red O (Figure 2E),
which confirmed the presence of bone and adipose
matrix following culture in defined osteogenic and adipo-
genic media, respectively. Positive safranin O staining of
sections from BMSC pellets and cell-seeded scaffoldsFigure 3 Colony-forming unit fibroblastic assay of passage 0 bone marrow-deriv
hypoxia. (A-J) Plastic-adherent bone marrow-derived mesenchymal stem cells we
that were stained with crystal violet for visualization. Dishes seeded with cells from
(K, L) Colony counts and diameters were measured and are reported as me
Representative photomicrographs of adherent cells from donor Y19 formefollowing culture in chondrogenic medium supported the
chondrogenic capacity of the adherent cells (Figure 2F).
Hypoxic isolation/expansion and differentiation augment
chondrogenic gene expression differentially within bone
marrow-derived mesenchymal stem cell-seeded collagen and
hyaluronic acid scaffolds
The impact of oxygen tension during isolation/expansion
and differentiation on BMSC chondrogenic gene expres-
sion within collagen and HA scaffolds was assessed with
RT-qPCR after 14 days of chondrogenic culture. For
BMSC-seeded collagen scaffolds, Hyp/Hyp constructs had
significantly higher aggrecan and collagen II mRNA ex-
pressions than Nrx/Nrx constructs (P <0.05; Figure 4A
and D), and a trend was seen for cartilage oligomeric
matrix protein (COMP) and collagen II/I ratio (P = 0.06
and 0.09, respectively; Figure 4B). Collagen I, collagen X,
and sex-determining region Y (SRY)-box 9 (SOX9) ex-
pressions and the ratio of collagen II/X were not signifi-
cantly different between oxygen tension groups (P = 0.20,
0.31, 0.22, and 0.40, respectively; Figure 4C, E, and F).
Within HA scaffolds, Hyp/Hyp BMSCs had significantly
higher aggrecan mRNA expression than Nrx/Nrx BMSCs
(P = 0.009; Figure 4A). COMP, collagen I, collagen II, col-
lagen X, and SOX9 gene expressions and the ratios ofed mesenchymal stem cells isolated and expanded under normoxia or
re isolated and expanded under hypoxia or normoxia and formed colonies
donor Z01 were excluded because of a lack of colony formation.
an ± standard error of the mean, and P values are listed.
d under hypoxic (M) and normoxic (N) culture.
Figure 4 (See legend on next page.)
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Figure 4 Reverse transcription-quantitative real-time polymerase chain reaction (RT-qPCR) analysis of gene expression within collagen and hyaluronic acid
(HA) scaffolds seeded with hypoxia- and normoxia-cultured bone marrow-derived mesenchymal stem cells (BMSCs). BMSCs were isolated/expanded under
normoxia or hypoxia, seeded within collagen or HA scaffolds, and subsequently differentiated under normoxia or hypoxia for 14 days in chondrogenic
medium. RT-qPCR was performed by using SYBR Green detection. (A-F) Data represent the mean± standard error of the mean (SEM) of constructs in
doublets based on oxygen tension group. (G-I) Data represent mean± SEM of constructs from the same donors pooled on the basis of oxygen tension
during isolation/expansion or differentiation. Statistical analysis is represented by the following: unlabeled indicates not significant, ^approaching significance
P= 0.05-0.10, *significant P <0.05, **significant P <0.01, ***significant P <0.001, and +monolayer control value that is significantly different than BMSC-seeded
scaffolds (P <0.05). COMP, cartilage oligomeric matrix protein; SOX9, sex-determining region Y (SRY)-box 9.
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ferent between oxygen tension groups (P = 0.72, 0.60, 0.13,
0.32, 0.99, 0.17, and 0.40, respectively; Figure 4B-F).
To further characterize the impact of oxygen tension
on gene expression, data were pooled on the basis of ex-
pansion oxygen tension and differentiation oxygen ten-
sion. BMSCs expanded under hypoxic conditions and
seeded within collagen scaffolds produced significantly
higher mRNA expression of collagen II and increased
ratios of collagen II/I and collagen II/X than BMSCs ex-
panded under normoxic conditions (P <0.01; Figure 4H).
However, aggrecan expression was not significantly dif-
ferent between groups (P = 0.19; Figure 4G). HA scaf-
folds seeded with BMSCs expanded under hypoxia
produced significantly higher mRNA expression of
aggrecan than BMSCs expanded under normoxia (P =
0.02; Figure 4G). Collagen II mRNA expression and
ratios of collagen II/I and collagen II/X were not
significantly different (P = 0.31 and 0.74, respectively;
Figure 4H). Within both collagen- and HA-based con-
structs, oxygen tension during expansion did not signifi-
cantly impact collagen I, collagen X, COMP, or SOX9
mRNA expression (P ≥0.29, 0.52, 0.14, and 0.16,
respectively).
Pooling of data on the basis of differentiation condition
indicated that hypoxic differentiation also augmented
chondrogenic gene expression. Collagen scaffolds seeded
with BMSCs and differentiated under hypoxia had signifi-
cantly higher aggrecan and collagen I mRNA expressions
(P = 0.008 and 0.03; Figure 4G) and approached statisti-
cally significant higher degrees of collagen II expression
(P = 0.09; Figure 4H). Collagen X mRNA expression was
marginally lower with hypoxic differentiation (P = 0.06).
SOX9 and COMP mRNA expressions and the ratios of
collagen II/I and collagen II/X were not significantly dif-
ferent between groups (P = 0.20, 0.02, 0.28, and 0.13,
respectively). HA scaffolds seeded with BMSCs and differ-
entiated under hypoxia had significantly higher mRNA ex-
pressions of aggrecan and collagen II (P <0.05; Figure 4G
and H) and an increased collagen II/I ratio that
approached significance (P = 0.09). SOX9, COMP, collagen
I, and collagen X mRNA expressions and the ratio of col-
lagen II/X were not significantly different between hypoxicand normoxic differentiation (P = 0.62, 0.28, 0.99, 0.31,
and 0.13, respectively).
Scaffold composition modulated chondrogenic gene ex-
pression of BMSCs. BMSC-seeded collagen scaffolds had
notably higher expressions of aggrecan, collagen II, and
SOX9 genes than BMSC-seeded HA scaffolds in the ma-
jority of oxygen tension groups (P <0.05; Figure 4A, D,
and F). Within pooled data, BMSCs seeded within colla-
gen scaffolds had augmented aggrecan, collagen II, SOX9,
and collagen X gene expressions relative to BMSCs seeded
within HA scaffolds regardless of expansion or differenti-
ation oxygen tension (P <0.01; Figure 4G, H, and I). Colla-
gen I gene expression was not significantly different
between scaffolds under hypoxic expansion, normoxic ex-
pansion, or normoxic differentiation (P ≥0.18). However,
under hypoxic differentiation, collagen I expression was
significantly higher in BMSCs seeded within collagen scaf-
folds relative to HA scaffolds (P = 0.03). COMP gene ex-
pression was significantly increased in BMSCs seeded on
collagen scaffolds only when expansion and differentiation
were performed under hypoxia (P <0.01).
Hypoxic isolation/expansion and differentiation enhance
chondrogenic extracellular matrix deposition differentially
within bone marrow-derived mesenchymal stem
cell-seeded collagen and hyaluronic acid scaffolds
Safranin O staining was used to assess ECM proteogly-
can content within BMSC-seeded collagen and HA
scaffolds after 14 days of chondrogenic differentiation
(Figure 5). Within collagen scaffolds, ECM was depos-
ited throughout areas of the scaffold with portions
containing intense proteoglycan staining noted in con-
structs that were exposed to hypoxia during the culture
period. Widespread staining with safranin O was par-
ticularly conspicuous in collagen scaffolds seeded with
BMSCs that underwent hypoxic isolation/expansion
prior to seeding (Hyp/Hyp and Hyp/Nrx). Hypoxic dif-
ferentiation also appeared to promote proteoglycan de-
position in constructs containing normoxia-expanded
BMSCs (Nrx/Hyp). Immunohistochemistry verified the
presence of collagen II within constructs that were ex-
posed to hypoxia during isolation/expansion or differen-
tiation (Figure 6). Collagen II content appeared to be
Figure 5 (See legend on next page.)
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Figure 5 Histological analysis of chondrogenic proteoglycan content within collagen and hyaluronic acid (HA) scaffolds seeded with hypoxia- and
normoxia-cultured bone marrow-derived mesenchymal stem cells (BMSCs). BMSCs were isolated/expanded under normoxia or hypoxia, seeded within
collagen or HA scaffolds, and subsequently differentiated under normoxia or hypoxia for 14 days in chondrogenic medium. Thereafter, constructs were
sectioned at 5-μm thickness and stained with safranin O and fast green. Photomicrographs represent collagen and HA acid scaffolds seeded with
BMSCs from three donors.
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throughout the culture period (Hyp/Hyp).
Within HA scaffolds, pockets of ECM were found
around HA fibers, which led to the creation of patchy tis-
sue after 14 days of culture (Figure 5). BMSCs that were
isolated and expanded under hypoxia demonstrated the
most pronounced safranin O staining (Hyp/Hyp and Hyp/
Nrx). Although ECM was also noted within HA scaffolds
seeded with BMSCs that underwent isolation/expansion
under normoxia (Nrx/Hyp and Nrx/Nrx), these con-
structs lacked safranin O staining. Hypoxic differenti-
ation appeared to augment proteoglycan content in
hypoxia-expanded BMSC-seeded HA scaffolds (Hyp/
Hyp) but not normoxia-expanded BMSC-seeded HA
scaffolds (Nrx/Hyp). Immunohistochemistry revealed
the presence of collagen II within ECM in constructs
that were exposed to hypoxia during the culture period
(Figure 6).
Quantitative GAG and GAG/DNA values were consistent
with histological staining of ECM proteoglycans (Figure 7A
and C). DNA quantities were not significantly different be-
tween oxygen tension conditions (P = 0.23; Figure 7B).Figure 6 Immunohistochemical analysis of collagen II content within colla
normoxia-cultured bone marrow-derived mesenchymal stem cells (BMSCs)
within collagen or HA scaffolds, and subsequently differentiated under nor
constructs were sectioned at 5-μm thickness, and collagen II immunostaini
labeling kit. Photomicrographs represent collagen and HA scaffolds seededGAG production and GAG/DNA in Hyp/Hyp constructs
were significantly higher than Nrx/Nrx constructs for
BMSCs seeded on both collagen and HA scaffolds (P <0.05
and P <0.01, respectively; Figure 7A and C). GAG/DNA
was also significantly higher in the Hyp/Nrx group than the
Nrx/Nrx group regardless of scaffold type (P <0.05;
Figure 7C). Data pooled on the basis of expansion oxygen
showed that hypoxic expansion improved GAG and GAG/
DNA regardless of scaffold type (P <0.01; Figure 7D and F).
Data pooled on the basis of differentiation oxygen tension
indicated no significant difference in GAG between hypoxic
differentiation and normoxic differentiation for collagen-
and HA-based constructs (P = 0.12 and 0.45, respectively;
Figure 7D). There was a trend for higher GAG/DNA in
BMSC-seeded collagen scaffolds differentiated under hyp-
oxia (P = 0.09; Figure 7F), and this effect was not seen in
BMSC-seeded HA scaffolds (P = 0.59).
Scaffold composition had a notable effect on ECM pro-
teoglycan deposition. In a comparison of collagen and HA
scaffold-based constructs within each oxygen tension
group, a significant difference was seen only in the Nrx/
Hyp group in which BMSC-seeded collagen scaffolds hadgen and hyaluronic acid (HA) scaffolds seeded with hypoxia- and
. BMSCs were isolated/expanded under normoxia or hypoxia, seeded
moxia or hypoxia for 14 days in chondrogenic medium. Thereafter,
ng was performed by using an aminoethylcarbazole-based peroxidase
with BMSCs from donor Z33.
Figure 7 Glycosaminoglycan (GAG) and DNA quantification of collagen and hyaluronic acid (HA) scaffolds seeded with hypoxia- and normoxia-cultured
bone marrow-derived mesenchymal stem cells (BMSCs). BMSCs were isolated/expanded under normoxia or hypoxia, seeded within collagen or HA scaffolds,
and subsequently differentiated under normoxia or hypoxia for 14 days in chondrogenic medium. (A-C) Data represent the mean± standard error of the
mean (SEM) of GAG quantity, DNA quantity and GAG/DNA within constructs from five donors in doublets based on oxygen tension group. (D-F) Data
represent mean± SEM of constructs from the same donors pooled on the basis of oxygen tension during expansion or differentiation. Statistical analysis is
represented by the following: unlabeled indicates not significant, ^approaching significance P= 0.05-0.10, *significant P <0.05, **significant P <0.01, and
***significant P <0.001.
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scaffolds (P <0.05; Figure 7A and C). Collagen scaffolds
that were seeded with normoxia-expanded BMSCs but
switched to hypoxic conditions for differentiation (Nrx/
Hyp) appeared to have improved GAG/DNA relative to
BMSCs that were exposed to sustained normoxic condi-
tions (Nrx/Nrx; P = 0.18; Figure 7C). This finding was sup-
ported by proteoglycans stained within BMSC-seeded
collagen scaffolds (Figure 5). This effect was not seen in
BMSC-seeded HA scaffolds, as Nrx/Hyp constructs had
stunted GAG/DNA values that were statistically equiva-
lent to Nrx/Nrx constructs (P = 0.97) and significantly
lower than Hyp/Hyp and Hyp/Nrx constructs (P <0.05;
Figure 7C). Pooled data showed higher proteoglycan
deposition by cells seeded on collagen scaffolds in com-
parison with HA scaffolds only when expansion was per-
formed under normoxia (P = 0.03 and 0.04 for GAG and
GAG/DNA, respectively; Figure 7D and F) and when dif-
ferentiation was performed under hypoxia (P = 0.02 for
GAG; Figure 7D).
Oxygen tension and scaffold composition modulate
cell-scaffold construct size during chondrogenesis
Collagen scaffolds seeded with BMSCs displayed signifi-
cant diameter contraction with time during chondrogenic
culture (P <0.001) to 60.1% ± 8.8% of the initial diameter
(Figure 8A). A significant difference was noted between
oxygen tension groups at day 7 of culture for BMSC-seeded collagen scaffolds (P= 0.004) but not at day 14 (P=
0.64). Based on pooled analysis, collagen scaffolds seeded
with BMSCs expanded under hypoxia had diameters that
approached significantly larger values (mean ± SEM of
68.2% ± 1.0%) at day 7 than those seeded with BMSCs ex-
panded under normoxia (65.0% ± 1.6%; P= 0.09). This differ-
ence was abolished by day 14 with diameters of 60.3% ±
1.5% and 60.0%± 1.7%, respectively (P= 0.88; Figure 8C).
BMSC-seeded collagen scaffolds that were differentiated
under hypoxia were more contracted (64.6%± 1.3%) than
BMSC-seeded scaffolds differentiated under normoxia at
day 7 (68.5% ± 1.4%; P= 0.04), but a significant difference
was not present by day 14 (61.2%± 1.7% and 59.1% ± 1.6%;
P= 0.36).
In contrast to collagen scaffold-based constructs, HA
scaffold-based constructs increased in size to 109.7% ±
4.2% of the initial diameter (P <0.001; Figure 8B). A sig-
nificant difference was noted between oxygen tension
groups at days 7 and 14 (P ≤0.003). Based on pooled ana-
lysis, expansion oxygen tension affected HA scaffolds
similarly to collagen scaffolds (Figure 8D). Although there
was not a significant difference between hypoxia- and
normoxia-expanded BMSC-seeded scaffolds at day 7
(113.0% ± 0.8% and 111.3% ± 0.9%, respectively; P = 0.15),
an effect became statistically significant by day 14 in which
hypoxic expansion led to increased diameters relative to
normoxic expansion (110.9% ± 0.7% and 108.4% ± 0.8%, re-
spectively; P = 0.02). Like BMSC-seeded collagen scaffolds,
Figure 8 Bone marrow-derived mesenchymal stem cell (BMSC)-seeded scaffold diameter during chondrogenesis. BMSCs were isolated/expanded under
normoxia or hypoxia, seeded within collagen or hyaluronic acid (HA) scaffolds, and subsequently differentiated under normoxia or hypoxia for 14 days in
chondrogenic medium. Construct diameter was assessed by using high-quality digital photography and ImageJ software. Data represent the mean ±
standard error of the mean of constructs containing (A) collagen scaffolds or (B) HA scaffolds seeded with BMSCs from three donors (five constructs
per donor) on the basis of oxygen tension group. Data were pooled on the basis of oxygen tension during expansion or differentiation for (C) collagen
scaffolds and (D) HA scaffold seeded with BMSCs. Statistical analysis is represented by the following: *significant P <0.05, **significant P <0.01, and
***significant P <0.001. NS, not significant; RM ANOVA, repeated measures analysis of variance.
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hypoxia were more contracted (109.5% ± 0.7%) than BMSC
scaffold differentiated under normoxia at day 7 (114.8% ±
0.7%; P <0.001). This effect was also seen at day 14
(108.2% ± 0.7% versus 111.1% ± 0.7%; P = 0.006).
Discussion
The major findings of this study are that incubation of
ovine BMSCs under hypoxia (3% O2) during isolation/
expansion and differentiation enhanced in vitro chon-
drogenesis within clinically approved porous collagen I
and esterified HA scaffolds and that porous scaffold
composition impacted the effect of oxygen tension on
chondrogenesis in this in vitro model.
Enhancement of chondrogenesis by hypoxic culture was
elucidated in BMSC-seeded porous scaffolds, which is an
important finding given that cell-seeded scaffolds are used
routinely as 3D models of in vitro chondrogenesis and clin-
ically in cell transplantation protocols for treatment of cartil-
age defects [7,21]. It was shown that chondrogenesis could
be promoted with hypoxic exposure during distinct isola-
tion/expansion and differentiation conditions. Althoughoxygen tension during distinct isolation/expansion and dif-
ferentiation periods was previously studied in detail within
pellet and hydrogel models in three studies, the results were
inconsistent and warranted further investigation [14,15,19].
In the study at hand, hyaline chondrogenic gene expression
of BMSC-seeded porous scaffolds was enhanced with hyp-
oxic exposure during both isolation/expansion and differen-
tiation. This is consistent with our previous findings in a
human BMSC pellet model [14]. ECM proteoglycan and
collagen II deposition was significantly improved with hyp-
oxic isolation/expansion based on histological and biochem-
ical analyses, whereas the impact of hypoxic differentiation
appeared to be less pronounced in this study. Although this
finding was demonstrated previously in human BMSC pel-
lets [14], others have reported highly significant findings fol-
lowing hypoxic differentiation in human BMSC pellet [19]
and porcine BMSC pellet and hydrogel [15] models. Differ-
ences in the effect of hypoxic differentiation between studies
could relate to variations in species, duration of incubation,
or culture protocols or a combination of these.
BMSC proliferation was also examined, and it was
found that hypoxic isolation and expansion to P2 only
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lation doublings per day were noted with hypoxic expos-
ure. However, BMSC counts at each passage, cumulative
population doublings, and CFU-F colony counts were not
significantly different between oxygen tension groups.
These results are consistent with previous work that
showed non-significant differences during early passages
and enhanced proliferation under hypoxia only with pro-
longed expansion beyond P2 [11,12].
Collagen and HA porous scaffolds were assessed in this
study given that these biomaterials are commonly used in
cartilage engineering applications and clinical BMSC trans-
plantation [1,2,4,5]. Both scaffolds were capable of fostering
gene expression and ECM formation consistent with
hyaline-like cartilage from BMSCs cultured in vitro. Chon-
drogenesis on collagen and HA scaffolds was responsive to
oxygen tension. However, differences were noted between
scaffolds in BMSC gene expression, ECM deposition, and
construct size during differentiation. BMSCs seeded and
cultured within collagen scaffolds had higher expressions of
aggrecan, collagen II, and SOX9 mRNA than BMSCs
within HA scaffolds regardless of oxygen tension, which
suggests that BMSC differentiation on collagen increases
the expression of genes associated with hyaline cartilage
relative to the HA. However, BMSCs within collagen
scaffolds also had higher mRNA expression of collagen X
regardless of oxygen tension and higher expression of colla-
gen I under hypoxic differentiation. These findings suggest
that culture on an HA scaffold could modulate gene ex-
pression more favorably for hyaline cartilage regeneration
by reducing the expression of collagens I and X, which are
associated with fibrocartilage and hypertrophic cartilage
[29,30] while maintaining the expression of genes associ-
ated with hyaline cartilage. Differences between scaffolds
were not as pronounced for ECM deposition as gene ex-
pression. In most oxygen tension groups, proteoglycan con-
tent was not significantly different between collagen- and
HA-based constructs. BMSC-seeded collagen scaffolds had
higher proteoglycan deposition specifically when expansion
was performed under normoxia and differentiation was
performed under hypoxia. Hypoxic differentiation appeared
to partially reverse dampening of chondrogenesis by nor-
moxic isolation/expansion on BMSC-seeded collagen scaf-
folds but not on BMSC-seeded HA scaffolds.
The underlying mechanisms for modulation of chondro-
genic gene expression and tissue formation by scaffold type
were not elucidated in this study but warrant further investi-
gation. BMSCs interact with collagen scaffolds via integrins
and with HA scaffolds through CD44 [31,32]. Scaffold char-
acteristics such as stiffness, biomaterial topography, and
pore dimension presumably alter intracellular signaling and
subsequent processes related to chondrogenesis through
these cell surface proteins [30]. Matrix stiffness was found
previously to regulate BMSC differentiation and tissueformation [33]. Topographical factors such as scaffold
fiber alignment and nanoscale surface features have been
shown to influence cell lineage commitment [34,35]. Fur-
thermore, content, size, and orientation of scaffold pores
appear to affect BMSC differentiation [36,37]. Porosity al-
ters oxygen diffusion through scaffolds, which could also
modulate chondrogenesis through the creation of oxygen
gradients [38].
BMSC-scaffold construct diameter was investigated
during culture given that fluctuations in construct size
occur with tissue formation and remodeling and ultim-
ately impact the suitability for constructs for implant-
ation in vivo. Size was maintained during culture in
BMSC-seeded HA scaffolds, whereas BMSC-seeded col-
lagen scaffolds exhibited progressive contraction with
time. Variation in size presumably involves a balance of
cell-scaffold interactions, biomaterial chemistry, scaffold
degradation, and ECM formation. Cell-mediated con-
traction that occurs through smooth muscle actin has
been described in detail within collagen-based constructs
[39]. HA is hydrophilic and may promote increased
scaffold swelling through water absorption relative to
collagen I [23]. Biomaterial degradation, hydrolysis, or
fragmentation may reduce the size of a construct if an
adequate amount of ECM has not been deposited by the
time that these processes occur [23,40,41]. In the study
at hand, it is not known how scaffold size affected chon-
drogenesis, although collagen scaffold contraction pre-
sumably led to increased cell density per volume of
scaffold, which could have modulated cell-cell interac-
tions and increased chondrogenesis [42]. It is also pos-
sible that contraction inhibited chondrogenesis, as it was
shown previously that contraction may promote differen-
tiation to a fibroblastic lineage [43,44]. Given that esteri-
fied HA scaffold size was maintained, the findings of this
study suggest that, in a clinical setting, implantation of
BMSCs on an esterified HA scaffold could promote better
early cartilage defect filling than on a collagen scaffold.
Construct size was also affected by incubator oxygen
tension. Both collagen and HA scaffold seeded with
BMSCs had increased diameters when BMSC isolation
and expansion were performed under hypoxia and differ-
entiation was performed under normoxia. Various mecha-
nisms could be involved: modulation of cell-mediated
contraction through smooth muscle actin and cytoskeletal
alteration [39], ECM proteoglycan formation [14,45],
crosslinking via lysyl oxidase [46], or degradation through
matrix metalloproteinases [47].
This study has some limitations. Although two defin-
ing criteria of mesenchymal stem cells—plastic adher-
ence and multipotential differentiation—were confirmed,
determination of cell surface antigens was not performed
to fulfill the third criterion of the Mesenchymal and
Tissue Stem Cell Committee [28]. This third criterion was
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method of BMSC isolation and expansion described in
our previous work, which included flow cytometric ana-
lysis of cell surface markers [14]. Secondly, the findings of
this study demonstrate enhanced in vitro chondrogenesis
with hypoxic culture, although it is still not clear whether
in vitro hypoxic culture improves chondrogenesis follow-
ing implantation within cartilage defects and prolonged
in vivo exposure to joint elements. Joints have been shown
to be hypoxic, and it is possible that this characteristic
could promote in vivo chondrogenesis regardless of the
in vitro culture conditions prior to construct implantation
[10]. Lastly, ovine rather than human BMSCs were used
in this study. Although sheep are routinely used as animal
models in cartilage engineering studies [13,48,49], differ-
ences between species could impact the clinical applicabil-
ity of our findings.Conclusions
BMSCs seeded on clinically relevant collagen I and esteri-
fied HA porous scaffolds displayed enhanced in vitro
chondrogenesis with hypoxic incubation during distinct
isolation/expansion and differentiation culture periods.
Hypoxic culture of BMSCs may therefore play a role in
improving cartilaginous tissue formation following trans-
plantation of BMSC-seeded scaffolds. Both collagen I and
esterified HA scaffold supported the creation of hyaline-
like engineered cartilage. However, differences were noted
in chondrogenic gene expression, ECM deposition, and
cell-scaffold construct size during differentiation that
could impact the choice of biomaterial for use in BMSC
transplantation protocols.Additional file
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